4AB:FRA
AbbVie Common Stock
€257.10
arrow_downward
-0.08%(-0.20) 1D
Nov 3, 8:35:30 AM GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
€257.10
High
€257.10
Low
€257.10
Mkt. cap
510.41B
Avg. vol.
111.00
Volume
0.00
52-wk high
€272.30
52-wk low
€167.55
No. of employees
57K
Open
€257.10
High
€257.10
Low
€257.10
Mkt. cap
510.41B
Avg. vol.
111.00
Volume
0.00
52-wk high
€272.30
52-wk low
€167.55
No. of employees
57K
News stories
From web sources and news partners
The Globe and Mail
·
3 hours ago
ABBV Q3 Earnings Call Highlights Raised Outlook and Pipeline Progress
Traders Union
·
12 hours ago
AbbVie shares drop almost 2% after strong Q3 results and raised dividend
GuruFocus
·
14 hours ago
AbbVie Stocks Decline 2.3% With RBC Target Increase Backing Its Immunology Transition
scanx.trade
·
16 hours ago
AbbVie Q3 Results: Revenue beats estimates at $17.404 billion
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57K
FoundedApr 10, 2012
HeadquartersNorth Chicago, Illinois, United States
SectorBiotechnology
Websiteabbvie.com